2015 Cotton O`Neil Cancer Center Annual Report - Stormont

2015 Annual Report
Stormont-Vail Cancer Center
1414 S.W. 8th Ave.
Topeka, Kansas 66606
stormontvail.org
2015 Annual Report • Stormont-Vail Cancer Center • Topeka, Kansas
A d u lt
and
P e d i at r i c
Care
Stormont-Vail Cancer Center, Topeka, Kansas
The physicians who practice at the Stormont-Vail Cancer Center include medical oncologists/hematologists
serving adults and pediatric patients, and radiation oncologists. All have offices within the cancer center. The
medical oncologists are Cotton-O’Neil physicians dedicated to the evaluation and treatment of adult and pediatric
patients with known or suspected hematology and oncology disorders. The radiation oncologists are with
Radiology and Nuclear Medicine and on the Stormont-Vail HealthCare medical staff.
Adult Medical Oncologists
Camille Adeimy, M.D.
Medical Degree: American University of Beirut, Faculty of
Medicine, Berirut, Lebanon
Residency: Internal Medicine, St. Louis
University, School of Medicine; VA St. Louis
Health Care System, St. Louis, Mo.,
Fellowship: Hematology and Oncology,
Loyola University, School of Medicine,
Maywood, Ill., Edward Hines, Jr. VA Hospital,
Hines, Ill.
Board Certifications: Internal Medicine
Dr. Adeimy has been a Cotton-O’Neil
physician since 2015.
David E. Einspahr, M.D.
Medical Degree: University of Nebraska School of Medicine,
Omaha
Residency: University of Kansas Medical Center,
Kansas City
Fellowship: Medical Oncology and Hematology;
University of Kansas Medical Center, Kansas City
Board Certifications: Internal Medicine,
Medical Oncology and Hematology
Clinical Interests: Clinical trials in medical
oncology and inherited cancer syndromes
Dr. Einspahr has been a Cotton-O’Neil physician
since 1991.
Karissa W. Boyd, D.O.
Medical Degree: University of Health Sciences College of
Osteopathic Medicine, Kansas City, Mo.
Residency: Internal Medicine, University of
Mississippi Medical Center, Jackson, Miss.
Fellowship: Hematology and Oncology,
University of Mississippi Medical Center,
Jackson, Miss.
Board Certifications: Internal Medicine
Clinical Interests: General oncology and
hematology, with special interest in breast
cancer.
Dr. Boyd has been a Cotton-O’Neil physician since 2009.
Mehmood Hashmi, M.D.
Medical Degree: Dow Medical College, Karachi, Pakistan.
Residency: Internal Medicine, University of
Oklahoma Health Sciences Center, Oklahoma
City, Okla.
Fellowship: Hematology/Oncology, University
of Kansas Medical Center, Kansas City
Clinical Interests: Diagnosis and treatment
of cancer related to the prostate, breast, lung,
kidneys, bladder, testes, head and neck, as well
as myeloma and lymphoma
Dr. Hashmi has been a Cotton-O’Neil physician since 2012.
Continued on back
2015 Annual Report • Stormont-Vail Cancer Center • Topeka, Kansas
Edwin L. Petrik, M.D.
Medical Degree: University of Kansas School of Medicine
Internship at Wesley Medical Center, Wichita
Residency: University of Kansas Medical
Center
Clinical Associate Professor in the
Department of Medicine Oncology at the
University of Kansas School of Medicine
Clinical Interests: All forms of solid tumors
and general internal medicine
Dr. Petrik has been a Cotton-O’Neil physician
since 1988.
Muhammad A. Salamat, M.D.
Medical Degree: Rawalpindi Medical College, University of
Punjab, Pakistan
Residency: (Internal Medicine): Vanguard
West Suburban Medical Center and Rush Oak
Park Hospital, Chicago, Ill.
Fellowship: Hematology/Oncology, Saint
Louis University School of Medicine,
St. Louis, Mo.
Dr. Salamat has been a Cotton-O’Neil
physician since 2013.
Radiation Oncologists
Russell E. Greene, M.D., DABR
Medical Degree and Internship: University
of California, Irvine Medical Center
Residency: Harvard University Joint
Radiation Center, Boston, Mass.; and
University of California Los Angeles Medical
Center
Board Certified ACR
Dr. Greene has been on the Stormont-Vail
Medical Staff since 1983.
John K. Ma, M.D., Ph.D.
Medical Degree, Ph.D., and Internship:
University of Mississippi School of Medicine,
Jackson, and University of Arkansas for
Medical Sciences, Little Rock, Ark.
Residency: University of Mississippi Medical
Center
Board Certified ABR
Dr. Ma has been on the Stormont-Vail
Medical Staff since 2015.
Pediatric Medical Oncologists/Hematologists
Youmna Othman, M.D.
Medical Degree: American University of Beirut, Beirut, Lebanon
Internship/Residency Pediatric: Women
and Children’s Hospital of Buffalo,
Buffalo, N.Y.
Fellowship Pediatric Hematology/
Oncology: University Hospitals, Case
Medical Center/Rainbow Babies and
Children’s Hospital, Cleveland, Ohio
Clinical Interests: Pediatric blood disorders
including hemophilia and thrombosis; sickle
cell disease; pediatric oncology specifically leukemia and solid
tumors
Dr. Othman has been a Cotton-O’Neil physician since 2012.
Jakica Tancabelic, M.D.
Medical Degree: University of Rijeka
Medical School, Rijeka, Croatia
Internship: Ogulin General Hospital,
Ogulin, Croatia
Pediatrics Residency: University of
Wisconsin, Marshfield, Wis.
Pediatric Hematology/Oncology
Fellowship: Columbia University, New
York City
Board Certification: Pediatrics; Pediatric Hematology Oncology
Clinical Interests: Pediatric blood disorders including
hemophilia and thrombosis, sickle cell disease; pediatric
oncology
Dr. Tancabelic has been a Cotton-O’Neil physician since 2010.
1414 S.W. 8th Ave.
Topeka, Kansas 66606
(785) 354-5300
stormontvail.org
2015 Annual Report • Stormont-Vail Cancer Center • Topeka, Kansas
About the Stormont-Vail Cancer Center – Serving Pediatric and Adult Patients
The Stormont-Vail Cancer Center is a specialty medical clinic within the Stormont-Vail
HealthCare network, providing outpatient services to children, adolescents and adults who
have a diagnosis of cancer or blood disorder. The 31,500-square-foot facility is located at
1414 S.W. Eighth Ave., just northeast of the main Stormont-Vail campus.
The center, opened in December 2006, consolidates all outpatient cancer services of
Stormont-Vail and Cotton-O’Neil. The center has a Trilogy Image-Guided Radiotherapy
linear accelerator systems in the state of Kansas and a PET/CT. It houses pediatric and adult
medical oncology practices, an infusion center and a clinical research center. There are also
ancillary services for patients offered such as genetic screening, nutritional counseling,
social work, pastoral care, and an outpatient palliative care program. Nurse navigators
provide assistance to patients and families as they move from diagnosis through treatment.
The Stormont-Vail Cancer Center received accreditation as a comprehensive cancer program
by The Commission on Cancer in 2009. The center also achieved accreditation for its
Radiation Therapy services through the American College of Radiology (ACR).
Stormont-Vail HealthCare is a founding research partner of the Midwest Cancer Alliance.
The MCA is a network of cancer professionals dedicated to increasing access to the latest
advancements in cancer care throughout the Heartland.
2014 Annual Cases Miscellaneous Mesothelioma Leukemia Myeloma Lymphoma Endocrine System Brain & Other Nervous System Urinary System Male Genital System Female Genital System Breast Skin SoB Tissue Bones & Joints Respiratory System Diges:ve system Oral Cavity & Pharynx 0 20 40 60 80 100 120 140 160 180 200 2015 Annual Report • Stormont-Vail Cancer Center • Topeka, Kansas
Standard 1.2: Cancer Committee Membership
The membership of the cancer committee is multidisciplinary, representing physicians from the diagnostic and
treatment specialties and nonphysicians from administrative and supportive services. Coordinators who are
responsible for specific areas of program activity are designated from the membership.
President/CEO - Randy Peterson
Cancer Center Director - Vicky McGrath, MBA, BSN, RN, OCN
Cancer Commitee Chair/Medical Oncologist - David Einsphar, M.D.
Cancer Liaison Physician - Scott Teeter, M.D.
Diagnostic Radiologist - Chrishopher Sheldon, M.D.
General Surgeon - William Sachs, M.D.
Pathologist - Sheila McMeekin, M.D.
Radiation Oncologist - Russell Greene, M.D.
Pediatric Oncology (alternate) - Jakica Tancabelic, M.D.
Clinic Oncology Nurse - Kristina Gurere, RN
Palliative Care - Robin Holthaus, BSN, RN, OCN, CHPN
Hospital Oncology Nurse - Salena Gillam, MBA, BSN, RN, BCNE
Palliative Care- Connie Rundle, APRN, ACHPN
Performance Improvement - Michele Guerrero, RTT
Cancer Conference Coordinator - Barb Whitehead
Quality Control Registry Data - Kate Bure, RHIT, CTR
Clinical Research - Mary Martell
Genetics - Ginger Reaves
Clinic Social Work - Kim Olson, LMSW
Dietitian - Karla Wessling
Pharmacy - Tyler Dieker
Community Outreach - Anita Fry
Rehabilitative Services - Toby Thompson
American Cancer Society - Ed Johnson
2015 Annual Report • Stormont-Vail Cancer Center • Topeka, Kansas
Standard 1.8: Monitoring Community Outreach
The community outreach coordinator monitors the effectiveness of community outreach activities on an annual
basis. The activities and findings are documented in a community outreach activity summary that is presented to
the cancer committee annually.
Report 2015: Summary of Community Outreach Activities
Community outreach organizations Stormont-Vail Cancer Center partners with:
• American Cancer Society • Leukemia & Lymphoma Society
• Topeka and Shawnee County Public Library
• Stormont-Vail Foundation
• Stormont-Vail Auxiliary
• Midland Hospice
• Race Against Breast Cancer
• Community social service agencies
Prevention and early-detection screening programs:
• Initiated HPV vaccine awareness campaign and began education of providers and staff about importance of the vaccine as a cancer prevention tool. Launched community campaign in November 2015.
• Skin cancer screening was held Saturday, April 25, 2015. This annual community screening event is
coordinated by Michele Guerrero, RTT. Screening was free. (See next page)
• Participated in breast cancer/mammography screening program through Race Against Breast Cancer.
We provide screening to 10 to 15 RABC patients through Jane C. Stormont Women’s Health Center each
month. Stormont-Vail sponsored the 5K Walk/Run Sept. 12, 2015 at Topeka West High School that benefits RABC.
Other community activities/education:
• Stormont-Vail Cancer Center sponsored the PBS screening Cancer: Emperor of All Maladies at KTWU on
March 21, 2015, and participated in a related community health fair.
• Stormont-Vail Cancer Center was a co-sponsor for the Shawnee County Relay for Life, which was May
29, 2015 at Hayden High School. There were more than 1,200 in attendance. We also sponsored other
Relays in the region.
• Stormont-Vail Cancer Center was a co-sponsor for the Cancer Survivors Day event Sunday, June 7,
2015 at the Kansas Expocentre. The event had a last minute challenge when electricity to the building at
the Kansas Expocentre shut off, but boxed dinners were still provided to all survivors and families who
stopped by.
• Provided community education through media interviews (print and broadcast), print advertisements,
and articles in Stormont-Vail’s community newsletter, Healthy Times. Topics included oncology rehabilitation, skin cancer screening, endobronchial ultrasound for diagnosis and staging of lung cancer, HPV
vaccine, 3D mammography and breast cancer.
• Support groups met regularly at cancer center: general support group, caregiver’s group, head and neck
support group, pet therapy, Kitchen Therapy through MCA, music therapy, Tai Chi, ACS’s Look Good
Feel Better program. Provided information about support services in the calendar of quarterly community newsletter, Healthy Times.
Distributed cancer awareness and prevention items at community and health fairs:
• KTWU health fair (March 21, 2015); Kansas Department of Health and Environment Health Fair (May 13, 2015); Journey for Jo
(May 30, 2015); Sunset Stroll in Overbrook (Sept. 21, 2015)
Presentations:
• Dr. Karissa Boyd spoke to more than 35 individuals at Temple Beth Sholom in Topeka on Friday, Oct.16. She spoke about
breast cancer and genetic mutations that can put a person at higher risk (such as the mutations in the BRCA1 gene or BRCA2
defects). Sinec one group with a higher risk is Ashkenazi Jews, this was of significant interest to the audience. Dr. Boyd explained
many things about breast cancer, connections to other cancers (such as uterine), and answered many questions (both during her
presentation and after the service).
2015 Annual Report • Stormont-Vail Cancer Center • Topeka, Kansas
Standard 4.1: Prevention Program; Standard 4.2 Screening Program
Skin Screening Clinic - April 25, 2015 - Stormont-Vail Cancer Center
SKIN SCREENING CLINIC:STORMONT-VAIL CANCER CENTER – April 25, 2015
Total Participants:
293
Race (Caucasian):
281
(Hispanic):
African American:
Asian:
Asian / Hispanic
Unknown:
(95.9%)
5
3
1
1
2
#Participants Referred:
#Participants Not Referred:
1st Skin Clinic
Repeat Clinic Use
Unknown:
Age Range:
94 (32.1%)
199 (67.9%)
145 (49.5%)
100 (34.1%)
48 (16.4%)
PARTICIPANT HOME LOCATION:
BROWN:
2
COFFEY:
5
FRANKLIN:
1
JACKSON:
3
JEFFERSON:
14
LYON:
8
OSAGE:
13
SHAWNEE:
243
WABAUNSEE:
2
CIMARRON,Co:
1
THE VILLAGES, FL:
1
8-90
SUN EXPOSURE:
Limited:
Moderate:
Extensive:
Unknown:
38 (13%)
181 (61.8%)
72 (24.6%)
2
PHYSICIAN #’S:
DR. Durst:
DR. Giessel:
DR. Sawyer
DR. Ricks
Judy Dowd PA:
DR. Barland:(Derm Resident)
DR. Prindaville:(Derm Resident)
54
29
50
52
27
29
52
ABNORMAL REFERRALS
REFERRALS THAT FU
REFERRALS THAT ARE NOT FU
REFERALS PLANNING TO FU
REFERRALS THAT WERE UNREACHABLE
REFERRAL WHO DIED
58
8
24
3
1
OF THOSE THAT FU – 1 MELANOMA WAS EXCISED
& SEVERAL BCC WERE REMOVED
FINDINGS
ABD
1
Acrochordon (Skin Tag): 4
Actinic Keratosis:
65
Café Au Lait Melasma:
1
Cyst:
1
Cherry Hemangioma:
16
Chest Lesion:
1
Benign Vascular Lesion 1
Congentital Nevus:
3
Dermatitis:
1
Dermatofibroma:
13
Dysplastic Nevus:
6
Eczema:
1
Edema S/p Surgery:
1
Epidermal Inclusion Cyst: 2
Erythema:
1
Folliculitis w Scaring: 1
Freckles:
2
Hemangioma:
4
Hernia with erosion:
1
Herpes Simplex:
1
Hx of Merkel Cell:
1
Hyperpigmentation:
1
Keloids:
1
Lentigo:
11
Lentgines:
6
Milia:
4
Mole:
73
Dark Mole:
1
Nevus:
6
Planter Wart:
1
Psoriasis:
1
Rosacea:
1
Sebaceous Cyst:
3
Sebaceous Hyperplasia: 5
Seborrheic Keratosis: 168
Irr Seborrheic Keratosis:1
Surgical Comp. of Rt Leg:1
Synovial Cyst:
1
Telangectasia:
2
Verrucae:
1
Vitiligo:
2
R/O Basal Cell Ca:
R/O Malignancy:
R/O Melanoma:
R/O Squamous Cell Ca:
R/O Foreign Body
Granuloma vs?
18
3
12
3
1
2015 Annual Report • Stormont-Vail Cancer Center • Topeka, Kansas
Standard 4.7: Monitoring Compliance with Evidence-Based Guidelines
Chronic Myelocytic Leukemia and compliance with monitoring its management
with TKI therapy
National Comprehensive Cancer Network (NCCN) guidelines suggest checking the control of CML while
under therapy with TKI every 3 months using a quantitative PCR (QPCR) assay for the bcr/abl transcript.
Patients cared for by Stormont-Vail Cancer Center with incident cases of CML during the period of 20092013 were the subject of this retrospective review. Patients were identified with CML by review of registry
records and EPC patient record search. The initial diagnosis confirming CML and presence of the Philadelphia chromosome and the bcr/abl transcript were identified and their records reviewed for subsequent
testing by QPCR technique for the bcr/abl transcript during therapy. The timeliness of follow-up and
what circumstances may have prevented this testing.
Results and Conclusions
Eleven new patients with CML were identified over the period 2009-2013 and their care reviewed
through march 2015 or date of last follow-up.
Three patients ended TKI therapy early. The remaining 8 patients had a cumulative total of 240 months
of follow-up reviewed. This would result in 80 time points for testing to be checked
In review of their testing patterns, on only 3 occasions were tests completely skipped for a period over
4 months. On 3 occasions the time frame for testing was 4 months rather than 3 months. The results
indicate excellent compliance with the desired frequency of follow-up and QPRCR testing suggested by
NCCN guidelines for the management of this disease. With the exception of a major TKI drug toxicity or
major concurrent illness, the experience over the period studied indicates excellent compliance with the
NCCN guidelines for monitoring and treatment of patients receiving TKI therapy for CML
2015 Annual Report • Stormont-Vail Cancer Center • Topeka, Kansas
Standard 4.7: Monitoring Compliance with Evidence-Based Guidelines
Review of risk assessment of Stage II colon cancer patients by MSI testing 2009-2013
The optimum management of Stage II colon cancer patients after surgery continues to evolve. These
groups of patients, after surgical resection of their cancer, generally have a good prognosis, though 5 year
disease-free survival of 60-80% is reported. To improve survival, efforts to treat patients who are at highest risk with adjuvant therapy are a reasonable extension to the care provided to Stage III patients currently. Risk stratification of Stage II patients has NCCN guidelines available for this assessment.
A review of the testing patterns in Stage II colon cancer patients less than age 70 in the years 2009-2013
was carried out. This cohort was selected because through the NCCN guideline states testing is appropriate in those over 70 years of age who meet the Bethesda Guidelines, it would not be possible to assess the
patients for these criteria from a chart review.
Methods: Patients with Stage II colon cancer were identified by data query for Stormont-Vail Cancer Registry for the years 2009-2013. From each year, patient groups of less than 50 years and less than 70 years
of age were made. Chart review then performed to determine if MSI or MMR testing was performed.
Results were the tabulated and assessed for presentation.
A. Patients less than 50 years. (8 patients)
•
7 of 8 had MSI testing, 1 declined testing with no risk factors except age
•
2 or 7 tested had abnormal MSI results (deficient)
•
1 of 2 in ECOG trial was abnormal for the 18 q LOH (loss of heterozygosity)
Therefore 3 of 7 tested or 3 of all <50 year old patients operated on at Stormont-Vail (8) had abnormal
genetic test results that influenced therapy,
B. Patients less than 70 years and greater than 50 years. Fifteen patients had surgery for colon cancer at
Stormont-Vail in this age group.
•
3 of 15 were tested for MSI
•
0 or 3 had abnormal MSI results
•
2 tested for MSI also has Oncotype DX assay with recurrence score of 10 and 12 (low risk).
Conclusion: Testing for MSI/MMR status in patients <50 years was performed in nearly all in this age
group. The testing resulted in a high rate of detecting tumor genetic changes that influence prognosis
and hence use of adjuvant therapy and in detection of Lynch Syndrome.
Screening patients between 50 and 70 years of age with Stage II colon cancer for MSI/MMR has not been
a common practice over the period reviewed. Current NCCN guidelines suggest MSI/MMR screening
should be performed in the assessment of risk of recurrence. Opportunities for discussion and education
on this aspect of care are reasonable suggestions.
2015 Annual Report • Stormont-Vail Cancer Center • Topeka, Kansas
In the Community
Cancer Center Staff Helps at KTWU Event
Stormont-Vail Cancer Center staff members
helped with a health fair that was part of a
special preview screening of a Ken Burns’ documentary based on Siddhartha Mukherjee’s
Pulitzer Prize-winning book “The Emperor of
All Maladies: The Biography of Cancer.” KTWU
hosted the event March 21, 2015 at Washburn
University.
The PBS documentary is a three-part, six-hour
documentary that premiered on PBS in twohour segments between March 30 and April 1 on
KTWU. Stormont-Vail sponsored the show.
Cancer center staff who assisted at the community event were Kayla Carpenter, Darcy
Graves and daughter Anastasia, Carolyn Wadley,
Deborah Edelman-Dolan and Jamia Nelson (not
pictured.)
CANCER CARE FOR ALL AGES … CLOSE TO HOME
Both adults and children receive compassionate, high-quality care closer to home
at the Stormont-Vail Cancer Center.
A continuum of care from diagnosis and treatment through survivorship is
available at the Stormont-Vail Cancer Center, 1414 S.W. Eighth Ave., Topeka. Providers
include adult and pediatric oncologists/hematologists and radiation oncologists.
Additional patient support comes from staff specialists in nutrition, social work,
chaplaincy, clinical research, genetic counseling and palliative care. On-site lab and
imaging services also give patients the convenience of getting all of their needs taken
care of at one location.
Please consider Stormont-Vail Cancer Center should you or a family member need
cancer care.
To learn more about our care team, please visit stormontvail.org or call (785) 270-4972.
Adult Medical Oncologists
Camille Adeimy, M.D.
Pediatric Medical
Oncologists/Hematologists
Karissa W. Boyd, D.O.
Youmna Othman, M.D.
David E. Einspahr, M.D.
Jakica Tancabelic, M.D.
Mehmood Hashmi, M.D.
Edwin Petrik, M.D.
Radiation Oncologists*
Muhammad A. Salamat, M.D.
Russell E. Greene, M.D.
John K. Ma, M.D., Ph.D.
*Radiation oncologists are with Radiology and Nuclear Medicine.
1414 S.W. Eighth Ave. • Topeka
stormontvail.org
CANCER PREVENTION FOR
YOUR KIDS: HPV VACCINATION
Protect your child from cancer. The Cancer Committee at the Stormont-Vail Cancer Center,
Cotton-O’Neil pediatricians and family physicians strongly encourage parents to talk to their
child’s doctor about the HPV vaccine.
The vaccination is most effective before exposure to infection, just like the measles and
other recommended childhood vaccines. It is recommended that the three-part vaccine series
be done at age 11-12 years old, but can be done up to age 26.
HPV, which stands for Human Papillomavirus, can cause cancers in women and men. There
are 26,000 of these cancers each year – and most could be prevented with the HPV vaccine.
HPV vaccines are safe, effective and recommended by the Centers for Disease Control and
Prevention.
Take action today. Help protect your child. Contact your
pediatrician or family physician today about providing
cancer prevention for your child.
1500 S.W. 10th Ave. • Topeka
stormontvail.org